Genesee Capital Advisors’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,283
| Closed | -$953K | – | 173 |
|
|
2026
Q1 | $953K | Buy |
9,283
+10
| +0.1% | +$1.13K | 0.4% | 63 |
|
|
2025
Q4 | $1.16M | Buy |
9,273
+669
| +8% | +$85.2K | 0.47% | 52 |
|
|
2025
Q3 | $1.15M | Buy |
8,604
+37
| +0.4% | +$4.86K | 0.5% | 52 |
|
|
2025
Q2 | $1.17M | Buy |
8,567
+374
| +5% | +$49.3K | 0.52% | 50 |
|
|
2025
Q1 | $1.09M | Sell |
8,193
-337
| -4% | -$42.9K | 0.54% | 42 |
|
|
2024
Q4 | $965K | Sell |
8,530
-45
| -0.5% | -$5.2K | 0.45% | 51 |
|
|
2024
Q3 | $978K | Sell |
8,575
-105
| -1% | -$11.5K | 0.47% | 49 |
|
|
2024
Q2 | $902K | Sell |
8,680
-252
| -3% | -$26.7K | 0.44% | 49 |
|
|
2024
Q1 | $1.02M | Sell |
8,932
-19
| -0.2% | -$2.18K | 0.56% | 44 |
|
|
2023
Q4 | $985K | Sell |
8,951
-5,026
| -36% | -$502K | 0.61% | 42 |
|
|
2023
Q3 | $1.35M | Sell |
13,977
-553
| -4% | -$58.1K | 0.97% | 31 |
|
|
2023
Q2 | $1.58M | Sell |
14,530
-273
| -2% | -$29.1K | 1.08% | 25 |
|
|
2023
Q1 | $1.5M | Buy |
14,803
+16
| +0.1% | +$1.69K | 1.06% | 22 |
|
|
2022
Q4 | $1.62M | Sell |
14,787
-1,020
| -6% | -$106K | 1.21% | 21 |
|
|
2022
Q3 | $1.53M | Sell |
15,807
-261
| -2% | -$27.8K | 1.16% | 19 |
|
|
2022
Q2 | $1.75M | Sell |
16,068
-2,437
| -13% | -$277K | 1.22% | 19 |
|
|
2022
Q1 | $2.19M | Sell |
18,505
-473
| -2% | -$58.6K | 1.14% | 24 |
|
|
2021
Q4 | $2.67M | Buy |
18,978
+209
| +1% | +$26.8K | 1.28% | 22 |
|
|
2021
Q3 | $2.22M | Buy |
+18,769
| New | +$2.31M | 1.09% | 27 |
|
|
2021
Q2 | – | Sell |
-19,089
| Closed | -$2.29M | – | 45 |
|
|
2021
Q1 | $2.29M | Sell |
19,089
-482
| -2% | -$57.1K | 1.36% | 19 |
|
|
2020
Q4 | $2.14M | Buy |
19,571
+281
| +1% | +$30.5K | 1.4% | 26 |
|
|
2020
Q3 | $2.1M | Sell |
19,290
-383
| -2% | -$38.9K | 1.73% | 13 |
|
|
2020
Q2 | $1.8M | Sell |
19,673
-3,017
| -13% | -$273K | 1.67% | 17 |
|
|
2020
Q1 | $1.79M | Sell |
22,690
-4,541
| -17% | -$379K | 1.71% | 13 |
|
|
2019
Q4 | $2.37M | Sell |
27,231
-416
| -2% | -$34.8K | 2.01% | 13 |
|
|
2019
Q3 | $2.31M | Buy |
27,647
+305
| +1% | +$25.9K | 2.14% | 12 |
|
|
2019
Q2 | $2.3M | Sell |
27,342
-864
| -3% | -$68K | 2.32% | 10 |
|
|
2019
Q1 | $2.25M | Buy |
28,206
+1,827
| +7% | +$136K | 2.71% | 9 |
|
|
2018
Q4 | $1.91M | Buy |
+26,379
| New | +$1.85M | 3.12% | 6 |
|
Other funds holding ABT
Genesee Capital Advisors's ABT Position: Q2 2026 in Review
Genesee Capital Advisors sold out of Abbott (ABT) in Q2 2026, closing a stake of 9,283 shares — an estimated $953K sold.
Genesee Capital Advisors first reported a position in ABT in Q4 2018 and held it in 29 quarters. The position peaked at $2.67M in Q4 2021. 2,972 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Genesee Capital Advisors reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
- Genesee Capital Advisors sold 9,283 Abbott shares in Q2 2026, an estimated $953K.
- Genesee Capital Advisors first reported a position in Abbott in Q4 2018 and held it in 29 quarters.
- Genesee Capital Advisors's Abbott position peaked at $2.67M in Q4 2021.
- 2,972 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Genesee Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.